Japan: New GCP Updates on Written Informed Consent
Japan ’s New Pharmaceutical Affairs Law, effective as of April 1, 2005, outlines new Good Clinical Practice (GCP) guidelines, including the specific requirements for informed consent and privacy statements. Previously, a verbal informed consent by the study participants was acceptable, but the... Read More